An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
908 Devices to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS) will participate in the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022, hosting a Fireside Chat at 2:00 p.m. Eastern Time. The event aims to communicate the company's innovations in mass spectrometry technology, addressing critical applications in life sciences, pharma, and more. Interested parties can access the live and archived webcast via the company's website.
908 Devices is headquartered in Boston and focuses on democratizing laboratory technology with its handheld and desktop devices.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participating in the upcoming Canaccord Genuity 42nd Annual Growth Conference.
908 Devices’ management is scheduled to host a Fireside Chat on Wednesday, August 10th at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices Inc. (Nasdaq: MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation and machine learning.